1-4 of 4
A Zimran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension,

A Mehta, H Ben Turkia, DE Gonzalez, M Kabra, EA Lukina, P Giraldo, I Kisinovsky, A Bavdekar, M-F Ben Dridi, N Gupta, PS Kishnani, EK Sureshkumar, N Barton, N Wang, E Crombez, K Bhirangi, A Zimran
Journal: Blood
Blood (2011) 118 (21): 3214.
https://doi.org/10.1182/blood.V118.21.3214.3214
Published: 2011
Journal Articles

Significance of abnormal neutrophil chemotaxis in Gaucher's disease [letter; comment]

A Zimran, D Elstein, A Abrahamov, GL Dale, M Aker, Y Matzner
Journal: Blood
Blood (1994) 84 (7): 2374–2375.
https://doi.org/10.1182/blood.V84.7.2374.2374
Published: 1994
Journal Articles

Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients

A Zimran, CE Hollak, A Abrahamov, MH van Oers, M Kelly, E Beutler
Journal: Blood
Blood (1993) 82 (4): 1107–1109.
https://doi.org/10.1182/blood.V82.4.1107.1107
Published: 1993
Journal Articles

Mutations in Jewish patients with Gaucher disease

E Beutler, T Gelbart, W Kuhl, A Zimran, C West
Journal: Blood
Blood (1992) 79 (7): 1662–1666.
https://doi.org/10.1182/blood.V79.7.1662.1662
Published: 1992